Textron marks Aerosonde UAS flight, 500th Citation Latitude rollout

Seeking Alpha - Tue, 09/22/2026 - 14:34

Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 - Slideshow

Seeking Alpha - Tue, 09/22/2026 - 14:33

Minerals Technologies Inc. (MTX) Analyst/Investor Day - Slideshow

Seeking Alpha - Tue, 09/22/2026 - 14:32

Eledon Pharmaceuticals, Inc. (ELDN) Presents at International Congress of The Transplantation Society 2026 - Slideshow

Seeking Alpha - Tue, 09/22/2026 - 14:32

Meta: AI Monetization Potential Is Finally Evident

Seeking Alpha - Tue, 09/22/2026 - 14:27

Maximize Local Search Prominence with Professional NAP Optimization

TalkMarkets - Tue, 09/22/2026 - 14:27
Maximize Local Search Prominence with Professional NAP Optimization

Invesco Summit Fund Q2 2026 Commentary

Seeking Alpha - Tue, 09/22/2026 - 14:27

Arhaus: Despite Industry Woes, The Company Offers Promise

Seeking Alpha - Tue, 09/22/2026 - 14:24

InfraCap MLP ETF Q2 2026 Commentary

Seeking Alpha - Tue, 09/22/2026 - 14:24

Leidos wins Army contract worth up to $127 million

Seeking Alpha - Tue, 09/22/2026 - 14:21

UBS: The Decline Is Not Surprising To Me Given Regulation Updates

Seeking Alpha - Tue, 09/22/2026 - 14:19

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy

Seeking Alpha - Tue, 09/22/2026 - 14:19

BlackRock Dynamic High Income Fund Q2 2026 Commentary

Seeking Alpha - Tue, 09/22/2026 - 14:16

AMD At $1 Trillion: Gamma Squeeze Unlikely To Last Forever

Seeking Alpha - Tue, 09/22/2026 - 14:13

John Hancock Classic Value Fund Q2 2026 Commentary

Seeking Alpha - Tue, 09/22/2026 - 14:09

Chopard Vanille Malika: Too Sweet? Honest Review | Perfuminate

TalkMarkets - Tue, 09/22/2026 - 14:05
Chopard Vanille Malika: Too Sweet? Honest Review | Perfuminate

Lifetime Brands: Q2'26 Aided By Tariff Refunds

Seeking Alpha - Tue, 09/22/2026 - 14:05

2027: The Year The CRE Debt Maturity Wall Triggers Peak Pain

Seeking Alpha - Tue, 09/22/2026 - 14:01

Columbia High Yield Municipal Fund Q2 2026 Commentary

Seeking Alpha - Tue, 09/22/2026 - 14:01

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria - Slideshow

Seeking Alpha - Tue, 09/22/2026 - 14:00

Pages